VentureWell’s Post

Avio Medtech Consulting presents Medtech MVP Pitch Contest Sponsors: Destination Medical Center (DMC), Fredrikson & Byron, P.A., Mobius Medical We're thrilled to announce the MedTech Pitch Contest 2024, hosted by Avio MedTech Consulting! This is your chance to showcase your groundbreaking innovation in the medical technology field. If you're gearing up for a late Seed or Series A funding round and have raised between $1M and $15M, we want to hear from you. If your pitch is selected, you will present your solution to esteemed judges and industry leaders at the MedTech MVP Conference in Minneapolis on June 17, 2024. Compete for the grand prize of $20,000 in non-dilutive funds and free registration to the conference. Network with top minds in medtech and gain invaluable exposure. 📅 Deadline for Submissions: May 15, 2024 💡 Whether you're a startup focused on medical devices, diagnostics, software as a medical device, or digital health, this is your platform to shine and propel your project to the next level. 🔗 Ready to make your mark? Submit your pitch deck and take the step towards transforming healthcare. For more details and to apply, visit our website. https://lnkd.in/g_UAnhSg 📢 Spread the word and let's drive innovation together! #MedTech2024 #Innovation #HealthcareTechnology #Startups #PitchContest #SeedFunding #MedTech Let's shape the future of healthcare together! Looking forward to seeing your innovative solutions. 🌟

General Prognostics (GPx) Inc., a Boston-based startup specializing in predictive heart monitoring, has secured an undisclosed investment from NEC X. This investment aligns with NEC X's goal to support healthcare innovation and coincides with GPx's entry into the Elev X! Boost program. This program offers startups like GPx a combination of funding, strategic partnerships, and integration with NEC X's tech ecosystem to facilitate global growth. GPx's innovative, implant-free device aims to revolutionize heart failure monitoring by providing non-invasive insights into patient conditions, akin to the impact of continuous glucose monitors on diabetes management. https://lnkd.in/gjt8WmxD

💡 Lessons for Medtech Startups: A 7-Step Framework Inspired by Neurotech The journey of building a medtech startup is challenging, with hurdles like regulatory approval, market access, and stakeholder engagement. While every niche has its unique demands, neurotech startups provide a great reference for navigating the complexities of medtech innovation. An insightful article outlines a 7-step framework designed for neurotech companies, but the principles are highly applicable to medtech as well: ✔️ Identify unmet clinical needs and gather stakeholder input early ✔️ Develop a robust intellectual property strategy to secure innovation ✔️ Navigate complex regulatory pathways strategically ✔️ Plan for reimbursement by demonstrating cost-effectiveness ✔️ Ensure data security and compliance with regulations ✔️ Craft a market access strategy tailored to the healthcare ecosystem ✔️ Prioritize expertise and resource allocation to focus on core goals Medtech entrepreneurs can adapt these lessons to their unique products and market dynamics to effectively cross the “Valley of Death” and bring life-changing technologies to patients. 🔗 Read the full article for inspiration here: https://shorturl.at/vEnvK

🚀 [#MedTech] Rhovica Neuroimaging AG, a Kanton Bern-based medtech start-up, has entered into a strategic partnership with M2care, a European venture studio specializing in health technologies. This collaboration aims to accelerate the development and commercialization of Rhovica’s SoNav™ system, an innovation designed to improve outcomes in neurocritical care. Founded in 2023 by neurosurgeons Martin Hlavica and Thomas Rhomberg, Rhovica focuses on solutions for severe cranial trauma and intracranial hemorrhages. Through its partnership with M2care, Rhovica gains financial backing and operational support to scale its technology. M2care’s expertise in medtech commercialization complements Rhovica’s innovations. Recognized for its market potential, Rhovica has won all three stages of the Venture Kick program and was a finalist in the Swiss Technology Award 2024. ➡️ https://lnkd.in/eqxRbFy2 📍With an international network of experienced and passionate professionals, GGBa promotes Western Switzerland throughout the world. Invest in Switzerland Bern Economic Development Agency

Giving voice to innovation - explaining complex science - that's what we do at TellMed Strategies. To learn more about how we do it, check out this article which resulted from TellMed being named one of the Fastest Growing Companies by Inc. Magazine last year 👇. https://bit.ly/4b3AsKU   #innovation #lifesciences #startup #publicrelations #PRTips

🔍 Medtech’s Capital Surge: Fueling Innovation in Healthcare The medtech sector is experiencing a significant influx of capital, driving innovation and shaping the future of healthcare. As highlighted in this insightful article from MedCity News, the investment boom in medtech is setting the stage for groundbreaking advancements and transforming patient care. 💰 Record-Breaking Investments: The medtech industry is seeing unprecedented levels of capital investment, with both venture capitalists and private equity firms pouring resources into innovative healthcare technologies. 🚀 Innovation Acceleration: This surge in funding is accelerating the development of cutting-edge medical devices, diagnostics, and digital health solutions that promise to revolutionize patient care and outcomes. 🌍 Global Impact: The capital infusion is not limited to the U.S.; international markets are also benefiting, leading to a more connected and advanced global healthcare landscape. 🔄 Shifting Dynamics: As medtech companies secure more funding, the industry is witnessing a shift towards more agile, tech-driven healthcare solutions that can rapidly adapt to changing needs and challenges. 🏥 Focus on Patient-Centric Solutions: The increased investment is enabling medtech companies to focus on creating patient-centric solutions, from wearable health monitors to AI-driven diagnostics, that improve the quality and accessibility of care. The capital surge in medtech is a game-changer for the healthcare industry, fostering an environment where innovation can thrive. With increased funding, medtech companies are well-positioned to deliver transformative solutions that will shape the future of healthcare. This is an exciting time for healthcare professionals, investors, and innovators alike. 👉 Read more here: #Medtech #HealthcareInnovation #DigitalHealth #VentureCapital #PatientCare #HealthTech #Investment #MedtechFunding #FutureOfHealthcare #TechInHealthcare

My Inc. Magazine article is out and on their home page! As a result of being named one of the Fastest Growing Companies by this publication, I was invited to share some learnings about how we, at TellMed Strategies, work to explain complex science. I hope you find it interesting and helpful. #innovation #lifesciences #startup #publicrelations #PRTips https://bit.ly/4b3AsKU

Over $180 million was raised in Medtech last week - Are you keeping up? Our Companies & Deals Database offers detailed profiles of thousands of early- and growth-stage Medtech and Healthtech companies. The database includes insights into their funding rounds, technologies, and key investors, giving you the information you need to stay ahead. What's Inside: • Comprehensive Profiles: Access detailed insights on over 5,950 Medtech companies and their deals. • Exclusive Content: Dive into 3,340 CEO pitches, executive summaries, and insights exclusively from LSI events. • Updated Regularly: Over 600+ new companies and deals were added to the database in 2023 alone. Recent Deals Spotlight: Beta Bionics   → Raise Amount: $60M Series E   → Technology: Closed-loop bionic pancreas device for the management of diabetes   → Investors: Wellington Management (led), Eventide Asset Management LLC, RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Perceptive Advisors, Marshall Wace myBiometry   → Raise Amount: $5M Seed Round   → Technology: Digital platform to remotely monitor and manage patients with chronic conditions   → Investors: Dexcom Ventures (led), CareSource Indiana, Elevate Ventures MintNeuro   → Raise Amount: £1 Seed Round   → Technology: Semiconductors for neural implants   → Investors: Empirical Ventures (led), Parkwalk Advisors, Imperial College London, Plug & Play, Excellis Holding, various angel investors ZAP Surgical Systems, Inc.   → Raise Amount: $78M Series E   → Technology: Gyroscopic precision radiosurgery platform for the treatment of brain tumors and conditions of the head and neck   → Investors: Baheal Medical Inc. (led), other strategic investors Subscribe to our Companies & Deals Database to explore detailed profiles of thousands of early- and growth-stage Medtech and Healthtech companies, with insights into funding rounds, technologies, and key investors giving you the information you need to stay ahead. Learn more on our website or reach out to our team today: https://lnkd.in/gy6Pt6bg

The medtech startup sector is booming like never before, propelled by tech breakthroughs, rising healthcare demands, and hefty investments. This surge is reshaping healthcare, bringing innovative solutions to age-old problems. VC firms, private equity investors, and big pharma are all diving in, recognising the potential. #medtech #venturecapital #medtechfunding

Trends in MedTech Startups: The Impact of Incubators and The Tape Lab’s Adhesive Innovations on Early Device Development In the dynamic realm of medical device funding, the emergence of family offices and incubators is revolutionizing opportunities for early-stage medtech companies. At The Tape Lab, we are at the cutting edge of this transformation, providing crucial adhesive technologies that enhance the functionality and reliability of medical devices. The evolution in funding strategies is bringing new players into the fold—family offices and incubators. These entities are not just investors; they're partners who provide financial backing and strategic insights, helping navigate the intricate path from concept to commercialization. At The Tape Lab, our adhesives are vital for ensuring that medical devices perform optimally while offering comfort and durability to users. We recognize the complexities of bringing a medical device from the drawing board to the market, especially considering the stringent regulatory standards and the necessity for precise, reliable functionality. Our solutions are designed to meet these challenges head-on. As funding landscapes shift towards more supportive and resource-rich environments for startups, The Tape Lab continues to play a pivotal role. We provide the essential adhesive technologies that startups need to ensure their innovations are not only viable but also ready for clinical use. Join us for our upcoming webinar, "Engineer's Blueprint for Skin-Safe Adhesive Devices," where we'll delve into how our adhesive innovations are revolutionizing wearable medical technology. Discover how partnering with The Tape Lab can elevate your product from a concept to a market-ready solution that improves patient outcomes and streamlines healthcare processes. Explore the possibilities with The Tape Lab, where innovation meets reliability. Visit us at The Tape Lab to learn more about our solutions and how they can transform your medical device projects. Together, let's shape the future of healthcare technology.